| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-08 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |